Identifying a new biomarker for painful nerve damage
Official title: Discovery and Validation of a Novel Response Biomarker Signature for Painful Peripheral Neuropathy
Funded at Lasmed, LLC · NIH-10917059 · Data updated 2026-11-12
This study is looking for a new way to measure ongoing nerve pain in people with peripheral neuropathy, so we can find better treatments that really work for you.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Lasmed, LLC NIH-funded |
| Lab location | 1 site (Mountain View, United States) |
| Project start | September 1, 2022 |
| Project end | April 30, 2026 |
| Funding year | 2025 |
| Award (this year) | $795,734 |
| NIH project number | 5R61NS122298-03 |
| Project ID | NIH-10917059 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals experiencing ongoing neuropathic pain due to conditions like diabetes, chemotherapy, or other causes.
✕Less likely to help
Patients with neuropathic pain that is not ongoing or those who do not have a diagnosis related to peripheral neuropathy may not benefit from this research.
What this research studies
This research aims to discover and validate a new biomarker signature that can indicate ongoing neuropathic pain in patients. By using a specialized technique to stimulate nerve fibers, the study will assess how these fibers respond to pain, which could lead to better-targeted pain therapies. The goal is to create a reliable biomarker that can help evaluate the effectiveness of treatments for painful peripheral neuropathy, a condition that significantly affects many individuals' quality of life. Patients participating in this research may undergo assessments that involve measuring their nerve responses to specific stimuli.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments for patients suffering from painful peripheral neuropathy.
How similar studies have gone: Previous research has shown promise in identifying biomarkers for pain, but this specific approach is novel and has not been extensively tested.
Where this research is happening
-
Lasmed, LLC
Mountain View, United States Active
Researchers
- Principal investigator: Nemenov, Mikhail I. — Lasmed, LLC
- Study coordinator: Nemenov, Mikhail I.
Related research
Other NIH-funded projects on the same topics.
-
Non-invasive, microscopic biomarkers to detect CIPN in chemotherapy patients
This grant aims to develop a non-invasive imaging method to measure nerve changes in patients undergoing chemotherapy to better understand and monitor chemotherapy-induced peripheral neuropathy (CIPN).
-
Novel pain biomarker for neuropathy that could guide therapy
A study to develop and test a biomarker that reflects how well peripherally acting pain medicines work for people with painful peripheral neuropathy.
-
Auricular vagus nerve stimulation to help HIV-related nerve pain in older adults
A new, non-invasive brain-nerve stimulation approach is being tested to help older adults living with HIV who have nerve pain.
-
Longitudinal study of how body-sense relates to chemotherapy nerve damage
This study follows people with breast or gastrointestinal cancer and healthy controls to see if brain processing of body sensations contributes to chemotherapy-induced nerve damage.
-
Understanding how early nerve excitement during chemotherapy leads to painful nerve damage
A cancer treatment study looks at why the nerve pain some patients get after paclitaxel may develop, by studying how nerves react during the infusion.
-
A new screen for chemotherapy-related nerve problems in young children
A clinician-scientist at Yale is developing a child-friendly survey to quickly screen for nerve-related side effects from cancer treatment in kids from birth to age 5.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.